68Ga-Trivehexin PET/CT Revealing Concomitant Papillary Thyroid Carcinoma and Parathyroid Adenoma

Clinical Nuclear Medicine 2026

View at publisher
Authors: Ilhan Sezgin, Dilara Denizmen Zorba, Ipek Gurel, Fatih Güzel, Halil Kömek
DOI: 10.1097/rlu.0000000000006489
Cited by: 1
References: 7

Abstract

68 Ga-Trivehexin PET/CT is an αvβ6 integrin-targeted imaging modality that has demonstrated promising potential in various malignancies. In addition, recent studies highlighted its high potential for detecting parathyroid pathologies. In this case report, we present the preoperative 68 Ga-Trivehexin PET/CT findings of a patient diagnosed with papillary thyroid carcinoma (PTC) and a parathyroid adenoma, emphasizing the potential role of this novel tracer in PTC imaging.

Fields of Study & Subjects

Parathyroid Disorders and Treatments Bone health and treatments Neuroendocrine Tumor Research Advances

Publication details

Journal / source
Clinical Nuclear Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
51
Issue
9
Pages
e768–e769
Publication date
28 April 2026
Language
EN